Human Immunodeficiency Virus Type 1 Vif Inhibits Packaging and Antiviral Activity of a Degradation-Resistant APOBEC3G Variant

Journal of Virology- United States

doi 10.1128/jvi.02694-06

Full Text

Abstract

Available in

Categories

Date

May 23, 2007

Authors

Publisher

American Society for Microbiology

Related search

Functional Analysis of Vif Protein Shows Less Restriction of Human Immunodeficiency Virus Type 2 by APOBEC3G

Journal of Virology

English

Identification of Amino Acid Residues in APOBEC3G Required for Regulation by Human Immunodeficiency Virus Type 1 Vif and Virion Encapsidation

Journal of Virology

English

Role of Vif in Human Immunodeficiency Virus Type 1 Reverse Transcription.

Journal of Virology

English

Exosomes Packaging APOBEC3G Confer Human Immunodeficiency Virus Resistance to Recipient Cells

Journal of Virology

English

Antiviral Activity of Polyoxomol Ybdoeuropate PM-104 Against Human Immunodeficiency Virus Type 1.

Chemical and Pharmaceutical Bulletin

English

ASK1 Restores the Antiviral Activity of APOBEC3G by Disrupting HIV-1 Vif-Mediated Counteraction

Nature Communications

Molecular Biology

English

Identification of a Novel HIV-1 Inhibitor Targeting Vif-Dependent Degradation of Human APOBEC3G Protein

Journal of Biological Chemistry

Molecular Biology

English

Triptolide Inhibits Human Immunodeficiency Virus Type 1 Replication by Promoting Proteasomal Degradation of Tat Protein

Infectious Diseases

English

Cytoskeleton Association and Virion Incorporation of the Human Immunodeficiency Virus Type 1 Vif Protein.

Journal of Virology

English